Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions.

U.S. customs officials said on Thursday they were investigating whether Indian solar company Waaree Energies sidestepped U.S.

Bank is increasing credit support to exporters and helping them diversify into newer markets, particularly Africa, following ...

Crisil Intelligence warns US tariffs pose a major risk to India's growth, impacting exports & investments. Domestic ...

High tariffs imposed by the United States on Indian goods pose a major risk to the country’s growth, Crisil Intelligence said ...

US tariffs on patented drugs won’t hit Indian pharma immediately, says Bhaskar Chakravorti, but future risk to generics ...

The latest wave of tariffs will take effect on October 1. Earlier, the Ministry of External Affairs (MEA) said it is ...

From the start of October, imported branded drugs will face a steep 100 per cent duty, while heavy-duty trucks will carry a ...

Trump’s tariffs have given India’s economy a sharp shock, forcing it to confront its vulnerabilities and accelerate ...

While Trump’s latest decision does not impact India much, the fast-changing tariff policies of the US are enough to induce ...

When multilateralism is under stress, BRICS has stood firm as a strong voice of reason and constructive change,” Jaishankar said in a social media post.

US tariffs on Indian goods linked to Russian oil purchases; negotiations ongoing for resolution, potential increase in US oil ...